News & Updates

Women more likely to undergo TAVR, at higher risk of in-hospital death

12 Nov 2023

Use of transcatheter aortic valve replacement (TAVR) is still not common among young patients, being restricted only to those at increased risk, reports a study in France. Significant differences in sex appear in patient demographics, selection of aortic valve replacement (AVR) modality, and patient outcomes.

Women more likely to undergo TAVR, at higher risk of in-hospital death

12 Nov 2023

Medical nutrition therapy a boon for adults with prediabetes

12 Nov 2023

Medical nutrition therapy (MNT) provided by a dietitian results in improved glycaemic outcomes, anthropometrics, blood pressure, and most lipid levels in prediabetic adults, according to a systematic review and meta-analysis.

Medical nutrition therapy a boon for adults with prediabetes

12 Nov 2023

Strawberries may stave off dementia

12 Nov 2023 by

Strawberries can potentially contribute to the prevention of dementia, with a small study suggesting that supplementation with whole-fruit strawberry powder helps improve memory in middle-aged adults.

Strawberries may stave off dementia

12 Nov 2023

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

11 Nov 2023

Adding vancomycin to cefazolin does not appear to confer significant benefits for the prevention of surgical site infections following arthroplasty in patients without known methicillin-resistant Staphylococcus aureus (MRSA) colonization, according to the results of the ASAP trial.

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

11 Nov 2023

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Consumption of total sugar, total glucose equivalents (TGE), added sugar, and fructose from added sugar and juice appears to increase the risk of coronary heart disease (CHD), reveals a study. However, intake of total fructose equivalents (TFE) and fructose from fruits and vegetables does not.

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

11 Nov 2023

Clinical presentation is more severe and survival much lower among patients with right heart thrombus and pulmonary embolism, who also require more advanced therapies, compared with those without a concomitant pulmonary embolism, a study has found. Thrombus mobility and size contribute to the development of concomitant pulmonary embolism.

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

11 Nov 2023

RADIANCE: BP lowering with renal denervation maintained at 6 months

11 Nov 2023 by

Across the RADIANCE trials, individuals treated with renal denervation remain to have a lower medication burden throughout the 6-month follow-up period even after the reintroduction of blood pressure (BP)-lowering drugs.

RADIANCE: BP lowering with renal denervation maintained at 6 months

11 Nov 2023

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023 by

Induction chemotherapy followed by chemoradiotherapy (CRT) significantly improves progression-free survival (PFS) and overall survival (OS) in patients with locally advanced cervical cancer compared with standard CRT alone, according to the INTERLACE trial presented at ESMO 2023.

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

11 Nov 2023 by

A post hoc analysis of the CHANCE-2 randomized controlled trial (RCT) demonstrates that ticagrelor-aspirin combination therapy is associated with a significantly lower risk of new stroke within 90 days vs the clopidogrel-aspirin combination in Chinese CYP2C19 loss‐of‐function allele carriers with minor stroke or transient ischaemic attack (TIA) without intracranial artery stenosis (ICAS).

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

11 Nov 2023

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

10 Nov 2023 by

Treatment with pyrotinib in combination with trastuzumab and docetaxel (tras/doc) results in longer progression-free survival (PFS) than placebo combined with tras/doc in patients with untreated HER2-positive metastatic breast cancer, a study has shown. In addition, the safely profile of tras/doc plus pyrotinib is manageable.

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

10 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Women more likely to undergo TAVR, at higher risk of in-hospital death

Women more likely to undergo TAVR, at higher risk of in-hospital death

Medical nutrition therapy a boon for adults with prediabetes

Medical nutrition therapy a boon for adults with prediabetes

Strawberries may stave off dementia

Strawberries may stave off dementia

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

Sugar, except from fruits and veggies, ups risk of CHD

Sugar, except from fruits and veggies, ups risk of CHD

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

Right heart thrombus with pulmonary embolism tied to poor survival, ICU admission

RADIANCE: BP lowering with renal denervation maintained at 6 months

RADIANCE: BP lowering with renal denervation maintained at 6 months

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer